Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Lorenzo Trippa

1-50 of 52 results

View this query on the Wikidata Query Service
Prognostic role of circulating exosomal miRNAs in multiple myeloma

scientific article published on 17 February 2017
Bayesian Adaptive Randomized Trial Design for Patients With Recurrent Glioblastoma

scientific article published on May 29, 2012
Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma

scientific article
Brain Malignancy Steering Committee clinical trials planning workshop: Report from the Targeted Therapies Working Group

scientific article published on August 26, 2014
Hazards of Hazard Ratios - Deviations from Model Assumptions in Immunotherapy

scientific article published on 01 March 2018
A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant-ineligible multiple myeloma

scientific article published on 08 May 2018
The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?

scientific article published on 6 March 2018
Progression-free survival: too much risk, not enough reward?

scientific article published on May 1, 2014
A Bayesian response-adaptive trial in tuberculosis: The endTB trial.

scientific article published on 23 August 2016
Combining progression-free survival and overall survival as a novel composite endpoint for glioblastoma trials

scientific article published on January 7, 2015
Bayesian response-adaptive designs for basket trials

scientific article published on 17 February 2017
Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma.

scientific article published on 20 February 2017
Designing Clinical Trials That Accept New Arms: An Example in Metastatic Breast Cancer

scientific article published on 22 May 2017
Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma

scientific article published on 04 October 2019
Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom's Macroglobulinemia patients

scientific article published on 26 October 2018
Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia

scientific article published on 16 April 2019
Pathological complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis

scientific article published on 11 February 2020
Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug Combinations

scientific article published on 26 April 2017
Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression

scientific article published on 22 May 2020
Adding experimental arms to platform clinical trials: randomization procedures and interim analyses

scientific article published on April 1, 2018
Design and Evaluation of an External Control Arm Using Prior Clinical Trials and Real-World Data

scientific article published on 07 June 2019
Reply to B. Freidlin et al

scientific article published on March 1, 2013
Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma

scientific article published on 27 March 2019
A Quantitative Framework for Modeling COVID-19 Risk During Adjuvant Therapy Using Published Randomized Trials of Glioblastoma in the Elderly

scientific article published on 27 April 2020
Sensitive detection of minimal residual disease in patients treated for early-stage breast cancer

scientific article published on 13 March 2020
A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer

scientific article published on 30 January 2020
A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastases

scientific article published on 20 September 2019
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant

scientific article published on 12 June 2020
Optimal Bayesian Adaptive Trials When Treatment Efficacy Depends on Biomarkers

scientific article published on November 17, 2015
To randomize, or not to randomize, that is the question: using data from prior clinical trials to guide future designs

scientific article published on 01 October 2019
Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and Temozolomide

scientific article published on 14 May 2020
Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial

scientific article published on 30 May 2019
Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical Trial

scientific article published on 03 September 2020
Lessons Learned from Deescalation Trials in Favorable Risk HPV-Associated Squamous Cell Head and Neck Cancer-A Perspective on Future Trial Designs

scientific article published on 16 September 2019
Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma

Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center

scientific article published on 16 September 2020
Genetic Subtypes of Smoldering Multiple Myeloma are associated with Distinct Pathogenic Phenotypes and Clinical Outcomes

Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study

Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia

Multi-study Factor Analysis

scientific article published on 08 March 2019
INNV-13. ALLELE: A CONSORTIUM FOR PROSPECTIVE GENOMICS AND FUNCTIONAL DIAGNOSTICS TO GUIDE PATIENT CARE AND TRIAL ANALYSIS IN NEWLY-DIAGNOSED GLIOBLASTOMA

Efficient computation of the joint probability of multiple inherited risk alleles from pedigree data

scientific article published on 25 June 2018
Reply to "Keynote 48: Is it really for everyone?"

scientific article published on 01 December 2020
Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia

Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials

scientific article published on 15 November 2019
Keynote 48: Is it really for everyone?

scientific article published on 04 May 2020
Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes

scientific article published on 01 January 2022
Getting it first versus getting it right: weighing the value of and evidence for progression-free survival as a surrogate endpoint for overall survival in glioblastoma

scientific article published on May 1, 2015
Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study

scientific article published on 24 April 2020
Deviation from the Proportional Hazards Assumption in Randomized Phase 3 Clinical Trials in Oncology: Prevalence, Associated Factors, and Implications

scientific article published on 25 July 2019

Paulina is supported by:

About Paulina

Help